Patents Assigned to INCOSPHARM CORPORATION
  • Patent number: 10617662
    Abstract: Provided are a novel autophagy activation-inducing compound or salt thereof, and a use thereof, and particularly, a medicinal composition for treatment and prevention of neurodegenerative diseases, type II diabetes, or atopy or psoriasis dermatitis, a cosmetic composition for alleviation of aging or atopy or psoriasis dermatitis, and a food composition, including the compound capable of inducing autophagy activation or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 23, 2017
    Date of Patent: April 14, 2020
    Assignee: INCOSPHARM CORPORATION
    Inventors: Chaejin Lim, Heung Jae Kim, Hwa-Jee Chung, Juyeon Jung, Kayoung Shin, Beom Cheol Kim, Seok Jeong Yoon, Myung Ho Kor, Seon Deok Kwon, Keedon Park
  • Patent number: 10618874
    Abstract: Disclosed is a novel compound, and a cosmetic composition for whitening and a pharmaceutical composition for preventing and treating a melanin hyperpigmentation disorder by activating autophagy to induce melanosome degradation and also by effectively inhibiting endocytosis of keratinocytes to interfere melanosome transfer into keratinocytes, thereby expressing an excellent effect on improvement, prevention, and treatment of a hyperpigmentation disorder induced from melanin.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: April 14, 2020
    Assignee: INCOSPHARM CORPORATION
    Inventors: Hwa-Jee Chung, Myung Ho Kor, Heung Jae Kim, Sung Woo Kim, Seok Jeong Yoon, Ju Yeon Jung, Ka Young Shin, Se Kyoo Jeong, Kee Don Park
  • Publication number: 20190160033
    Abstract: Provided are a novel autophagy activation-inducing compound or salt thereof, and a use thereof, and particularly, a medicinal composition for treatment and prevention of neurodegenerative diseases, type II diabetes, or atopy or psoriasis dermatitis, a cosmetic composition for alleviation of aging or atopy or psoriasis dermatitis, and a food composition, including the compound capable of inducing autophagy activation or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 23, 2017
    Publication date: May 30, 2019
    Applicant: INCOSPHARM CORPORATION
    Inventors: Chaejin LIM, Heung Jae KIM, Hwa-Jee CHUNG, Juyeon JUNG, Kayoung SHIN, Beom Cheol KIM, Seok Jeong YOON, Myung Ho KOR, Seon Deok KWON, Keedon PARK
  • Patent number: 9359401
    Abstract: The present invention relates to a peptide analog or a pharmaceutically acceptable salt thereof with excellent moisturizing effect, and use thereof for moisturization. More specifically, the present invention relates to a novel peptide analog or a pharmaceutically acceptable salt thereof, a method for preparation thereof, a moisturizing cosmetic composition comprising the same as an active ingredient, and a pharmaceutical composition for prevention and treatment of xeroderma.
    Type: Grant
    Filed: May 22, 2012
    Date of Patent: June 7, 2016
    Assignee: INCOSPHARM CORPORATION
    Inventors: Kee-Don Park, Chae-Jin Lim, Seok-Jeong Yoon, Seon-Deok Kwon
  • Patent number: 9180082
    Abstract: The present invention relates to a biotin-conjugated hexapeptide-2 derivative or a pharmaceutically acceptable salt thereof and use thereof. More particularly, the present invention relates to a biotin-conjugated hexapeptide-2 derivative or a pharmaceutically acceptable salt thereof, a preparation method thereof, a composition including the same as an active ingredient, and a method for improving wrinkles and inhibiting skin aging using the same.
    Type: Grant
    Filed: March 27, 2013
    Date of Patent: November 10, 2015
    Assignee: INCOSPHARM CORPORATION
    Inventors: Kee-Don Park, Chae-Jin Lim, Seok-Jeong Yoon, Seon-Deok Kwon
  • Publication number: 20140113868
    Abstract: The present invention relates to a peptide analogue or a pharmaceutically acceptable salt thereof with excellent moisturizing effect, and use thereof for moisturization. More specifically, the present invention relates to a novel peptide analogue or a pharmaceutically acceptable salt thereof, a method for preparation thereof, a moisturizing cosmetic composition comprising the same as an active ingredient, and a pharmaceutical composition for prevention and treatment of xeroderma.
    Type: Application
    Filed: May 22, 2012
    Publication date: April 24, 2014
    Applicant: INCOSPHARM CORPORATION
    Inventors: Kee-Don Park, Chae-Jin Lim, Seok-Jeong Yoon, Seon-Deok Kwon